Form 8-K - Current report:
SEC Accession No. 0001513162-19-000185
Filing Date
2019-08-21
Accepted
2019-08-21 17:00:24
Documents
24
Period of Report
2019-08-21
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K form8k.htm 8-K 26108
2 EXHIBIT 99.1 exhibit99_1.htm EX-99.1 5310
3 GRAPHIC slide1.jpg GRAPHIC 63397
4 GRAPHIC slide2.jpg GRAPHIC 137156
5 GRAPHIC slide3.jpg GRAPHIC 92663
6 GRAPHIC slide4.jpg GRAPHIC 125694
7 GRAPHIC slide5.jpg GRAPHIC 118032
8 GRAPHIC slide6.jpg GRAPHIC 119230
9 GRAPHIC slide7.jpg GRAPHIC 105624
10 GRAPHIC slide8.jpg GRAPHIC 80889
11 GRAPHIC slide9.jpg GRAPHIC 63178
12 GRAPHIC slide10.jpg GRAPHIC 109676
13 GRAPHIC slide11.jpg GRAPHIC 89975
14 GRAPHIC slide12.jpg GRAPHIC 91194
15 GRAPHIC slide13.jpg GRAPHIC 87501
16 GRAPHIC slide14.jpg GRAPHIC 120841
17 GRAPHIC slide15.jpg GRAPHIC 113350
18 GRAPHIC slide16.jpg GRAPHIC 83826
19 GRAPHIC slide17.jpg GRAPHIC 129946
20 GRAPHIC slide18.jpg GRAPHIC 82328
21 GRAPHIC slide19.jpg GRAPHIC 126626
22 GRAPHIC slide20.jpg GRAPHIC 98274
23 GRAPHIC slide21.jpg GRAPHIC 103390
24 GRAPHIC slide22.jpg GRAPHIC 121701
  Complete submission text file 0001513162-19-000185.txt   3153420
Mailing Address 3150 ALMADEN EXPRESSWAY, SUITE 250 SAN JOSE CA 95118
Business Address 3150 ALMADEN EXPRESSWAY, SUITE 250 SAN JOSE CA 95118 408-708-9808
Anixa Biosciences Inc (Filer) CIK: 0000715446 (see all company filings)

EIN.: 112622630 | State of Incorp.: DE | Fiscal Year End: 1031
Type: 8-K | Act: 34 | File No.: 001-37492 | Film No.: 191043560
SIC: 8071 Services-Medical Laboratories